Introduction
Sargassum naozhouense Tseng et Lu-one species of the Sargassum genus (phylum Phaeophyta, class Cyclosporeae, order Fucales, family Sargassaceae), called "black vegetable"-is distributed widely in the coastal region of the Leizhou Peninsula of China, and can be cultivated commercially under the northern South China Sea's high-temperature condition [1] [2] [3] [4] . It has a series of pharmaceutical functions in Chinese folk medicine, such as treating infections, laryngitis, dieresis, and other ailments [3] . However, there have been few studies of the chemical constituents that reported primarily carbohydrates, proteins, minerals, dietary fiber, sulfated polysaccharide, and phlorotanns from the brown seaweed S. naozhouense [3, 5, 6] . In order to fully utilize this species and obtain new bioactive compounds from seaweeds being able to produce a great variety of secondary metabolites characterized by a broad spectrum of biological activities, we investigated the brown alga S. naozhouense. Previous chemical research on this species has resulted in the isolation of 1-O-hexadecanoyl glycerol, hexadecanoyl glycerol, pheophytin a, β-sitosterol, mannitol, uracil, thymine, p-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 4-hydroxyphthalide, and 2′-deoxythmidine [2] . Now, in our further chemical investigation on the EtOH extract of S. naozhouense, a new C11-norisoprenoid derivative (namely sargassumone (1)), and six known norisoprenoids (2-7), together with a known highly oxygenated cyclopentenone (8) (Figure 1 ) were obtained. Compounds 2-8 were also isolated from S. naozhouense for the first time.
In addition, brown algae present anti-diabetic, antioxidant, and antimicrobial effects [7] [8] [9] , and so compound 6 was tested for its inhibitory activity against protein tyrosine phosphatase 1B (PTP1B), used as a potential therapeutic drug target in the treatment of type 2 diabetes, antioxidant activity with 1,1-diphyl-2-picrylhydrazyl (DPPH) free radicals, and antimicrobial activities against resistant clinical isolates of Candida albicans, methicillin-resistant Staphylococcus aureus (MRSA) , and Escherichia coli. 
Results and Discussion
Compound 1 was obtained as a colorless oil, and its molecular formula was determined as C11H18O5 based on electron impact ionization source-mass spectrum (EI-MS) at m/z 212 [M − H2O] + and NMR spectra data (see supplementary materials). The 1 H-NMR spectra showed the resonances of three methyl singlets at δ 0.86 (3H, s), 0.95 (3H, s), and 1.14 (3H, s), four aliphatic protons at the range of δ 1.27-2.07 attributable to two methylene groups, two hydroxymethine protons at δ 3.79 (1H, m) and 4.93 (1H, d, J = 6.0 Hz), and three exchangeable protons at δ 5.36 (9-OH, s), 4.55 (6-OH, d, J = 4.5 Hz), and 7.03 (2-OH, d, J = 6.0 Hz). The 13 C-NMR (Table 1) , distortionless enchancement by polarization transfer (DEPT), and HMQC spectra revealed the presence of eleven carbons-namely, three methyl carbons, two methylene carbons, two oxymethine carbons, three quaternary carbons (two bearing oxygen), and one ketone carbon, which accounted for the three degrees of unsaturation. The 1 H-1 H COSY correlation ( Figure 2 ) from H2-5 to H-6 and H-6 to H2-7, which established a moiety of CH2CHOHCH2, in conjunction with the key HMBC correlations from H3-10 to C-4, C-5, C-9, and C-11, H3-12 to C-7, C-8, and C-9, 9-OH to C-3, C-8, and C-9, and 2-OH to C-2 and C-3 (Figure 2 ), disclosed the structure of hexahydro-2,6,9-trihydyoxy-4,4,8-trimethyl-3(2H)-benzofuranone, which was the deacetyl derivative of compound 2 isolated from the brown alga Undaria pinnatifida as a new compound. The NOESY correlations (Figure 3 ) of H-6/Ha-7, Ha-7/H3-12, H3-12/2-OH and 9-OH, 9-OH/H3-10 (δ 0.86, s), and H-2/H3-11 (δ 0.95, s) clarified H-6, Ha-7, H3-12, 2-OH, 9-OH, and H3-10 (δ 0.86, s) being on the same side in opposite to H-2 and H3-11 (δ 0.95, s), which were similar to those of compound 2 whose stereochemistry was 2R, 6S, 8S, 9S [10] , and so the stereochemistry of 1 may be 2R, 6S, 8S, 9S. By using a Gaussian-03 package (B3LYP/6-31 G(d) level) for minimizing energy calculation, molecular modeling of 1 suggested its most stable conformation was 2R, 6S, 8S, and 9S, which was in agreement with the NOESY results. Furthermore, the calculated circular dichroism (CD) curve of compound 1 was similar to those of compound 2 (Figures 4 and 5) , which indicated the same In addition, brown algae present anti-diabetic, antioxidant, and antimicrobial effects [7] [8] [9] , and so compound 6 was tested for its inhibitory activity against protein tyrosine phosphatase 1B (PTP1B), used as a potential therapeutic drug target in the treatment of type 2 diabetes, antioxidant activity with 1,1-diphyl-2-picrylhydrazyl (DPPH) free radicals, and antimicrobial activities against resistant clinical isolates of Candida albicans, methicillin-resistant Staphylococcus aureus (MRSA), and Escherichia coli.
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Compounds 2-8 were identified as (2R,6S,8S,9S)-hexahydro-2,9-dihydroxy-4,4,8-trimethyl-6-acetyloxy-3(2H)-benzofuranone (2) [10] , (6S,8S,9R)-hexahydro-6,9-dihydroxy-4,4,8-trimethyl-2(2H)-benzofuranone (3) [10] , (6S,8S,9R)-hexahydro-6,9-dihydroxy-4,4,8-trimethyl-2(2H)-benzofuranone (4) [10] , loliolide (5) [10, 11] , (+)-epiloliolide (6) [10] [11] [12] , spheciospongones A (7) [13] , and (+)-kjellmanianone (8) [14] , respectively, by comparison of their physical and spectroscopic data with those in the literature. absolute configuration between 1 and 2. Thus, the structure of 1 was determined to be (2R,6S,8S,9S)-hexahydro-2,6,9-trihydroxy-4,4,8-trimethyl-3(2H)-benzofuranone, named sargassumon, which is the first example from natural sources to our knowledge. Compounds 2-8 were identified as (2R,6S,8S,9S)-hexahydro-2,9-dihydroxy-4,4,8-trimethyl-6-acetyloxy-3(2H)-benzofuranone (2) [10] , (6S,8S,9R)-hexahydro-6,9-dihydroxy-4,4,8-trimethyl-2(2H)-benzofuranone (3) [10] , (6S,8S,9R)-hexahydro-6,9-dihydroxy-4,4,8-trimethyl-2(2H)-benzofuranone (4) [10] , loliolide (5) [10, 11] , (+)-epiloliolide (6) [10] [11] [12] , spheciospongones A (7) [13] , and (+)-kjellmanianone (8) [14] , respectively, by comparison of their physical and spectroscopic data with those in the literature. absolute configuration between 1 and 2. Thus, the structure of 1 was determined to be (2R,6S,8S,9S)-hexahydro-2,6,9-trihydroxy-4,4,8-trimethyl-3(2H)-benzofuranone, named sargassumon, which is the first example from natural sources to our knowledge. Compounds 2-8 were identified as (2R,6S,8S,9S)-hexahydro-2,9-dihydroxy-4,4,8-trimethyl-6-acetyloxy-3(2H)-benzofuranone (2) [10] , (6S,8S,9R)-hexahydro-6,9-dihydroxy-4,4,8-trimethyl-2(2H)-benzofuranone (3) [10] , (6S,8S,9R)-hexahydro-6,9-dihydroxy-4,4,8-trimethyl-2(2H)-benzofuranone (4) [10] , loliolide (5) [10, 11] , (+)-epiloliolide (6) [10] [11] [12] , spheciospongones A (7) [13] , and (+)-kjellmanianone (8) [14] , respectively, by comparison of their physical and spectroscopic data with those in the literature. Compound 6 was evaluated for its inhibitory activity as inhibitor of PTP1B in vitro, and the results showed it showed no or weak activity against PTP1B with IC50 value of over 50 μmol/L in Table 2 . Meanwhile, compound 6 was also evaluated for its antioxidant activity with DPPH free radicals, and the results showed certain antioxidant activity with IC50 value of 16.65-17.35 mM in Table 3 . In addition, compound 6 was assayed for its antimicrobial activity by the disc diffusion method in vitro. The results of inhibition zones showed that compound 6 exhibited antimicrobial activity against tested resistant strains such as Candida albicans, MRSA, and Escherichia coli, with inhibition zones ranging from 6.30 to 8.33 mm at a concentration of 4.08 μM in Table 4 , which were lower than those of tetracycline used as a positive control at the same concentration. Interestingly, compound 6 exhibited better antimicrobial activities against tested resistant isolates than those of penicillin used as another positive control at the same concentration, which showed no or very weak activity. Furthermore, compound 6 showed antimicrobial activity against the standard strain (ATCC 29213, a non-antibiotic-resistant strain), with the inhibition zone of 7.10-7.90 mm at a concentration of 4.08 μM. Compound 6 was evaluated for its inhibitory activity as inhibitor of PTP1B in vitro, and the results showed it showed no or weak activity against PTP1B with IC50 value of over 50 μmol/L in Table 2 . Meanwhile, compound 6 was also evaluated for its antioxidant activity with DPPH free radicals, and the results showed certain antioxidant activity with IC50 value of 16.65-17.35 mM in Table 3 . In addition, compound 6 was assayed for its antimicrobial activity by the disc diffusion method in vitro. The results of inhibition zones showed that compound 6 exhibited antimicrobial activity against tested resistant strains such as Candida albicans, MRSA, and Escherichia coli, with inhibition zones ranging from 6.30 to 8.33 mm at a concentration of 4.08 μM in Table 4 , which were lower than those of tetracycline used as a positive control at the same concentration. Interestingly, compound 6 exhibited better antimicrobial activities against tested resistant isolates than those of penicillin used as another positive control at the same concentration, which showed no or very weak activity. Furthermore, compound 6 showed antimicrobial activity against the standard strain (ATCC 29213, a non-antibiotic-resistant strain), with the inhibition zone of 7.10-7.90 mm at a concentration of 4.08 μM. Compound 6 was evaluated for its inhibitory activity as inhibitor of PTP1B in vitro, and the results showed it showed no or weak activity against PTP1B with IC 50 value of over 50 µMol/L in Table 2 . Meanwhile, compound 6 was also evaluated for its antioxidant activity with DPPH free radicals, and the results showed certain antioxidant activity with IC 50 value of 16.65-17.35 mM in Table 3 . In addition, compound 6 was assayed for its antimicrobial activity by the disc diffusion method in vitro. The results of inhibition zones showed that compound 6 exhibited antimicrobial activity against tested resistant strains such as Candida albicans, MRSA, and Escherichia coli, with inhibition zones ranging from 6.30 to 8.33 mm at a concentration of 4.08 µM in Table 4 , which were lower than those of tetracycline used as a positive control at the same concentration. Interestingly, compound 6 exhibited better antimicrobial activities against tested resistant isolates than those of penicillin used as another positive control at the same concentration, which showed no or very weak activity. Furthermore, compound 6 showed antimicrobial activity against the standard strain (ATCC 29213, a non-antibiotic-resistant strain), with the inhibition zone of 7.10-7.90 mm at a concentration of 4.08 µM. 
Materials and Methods

General
Optical rotations were measured with a Perkin-Elmer model 341 polarimeter (Perkin Elmer Corporation, Boston, MA, USA). NMR spectra were recorded on a Bruker Avance 500 NMR spectrometer (Bruker Corporation, Faellanden, Switzerland). HR-ESI-MS spectra were recorded on a Bruker maXis impact mass spectrometer (Bruker Corporation, Bremen, Germany). EI-MS data were measured on a Thermo Scientific DSQ mass spectrometer (Thermo Fisher Scientific Corporation, New York, NY, USA). CD spectra were recorded on a Chirascan CD spectropolarimeter (Applied Photophysics Ltd., Surrey, UK). Column chromatography was performed on silica gel (100-200 and 200-300 mesh, Yantai Jiangyou Silica Gel Development Co., Ltd., Yantai, China) and Sephadex LH-20 (Pharmacia, Uppsala, Sweden). Thin-layer chromatography (TLC) was performed on pre-coated silica gel GF 254 plates (Yantai Jiangyou Silica Gel Development Co., Ltd., Yantai, China), visualization under UV light, or by heating after spraying with 5% H 2 SO 4 -EtOH (v/v). Organic solvents for column chromatography were either spectral grade or analytical reagents and obtained from Guangzhou Dongju Test Instrument Co., Ltd. (Guangzhou, China).
Protein tyrosine phosphatase 1B (PTP1B), p-nitrophenyl phosphate disodium (pNPP), 3-(N-morpholino)-propanesulfonic acid (MOPS), and dimethyl sulphoxide (DMSO) were obtained from the National Center for Drug Screening (Shanghai, China). The clinical resistant strains (Candida albicans 615, MRSA 315, and Escherichia coli 234) were isolated from phlegm samples provided by Guangdong General Hospital (Guangdong, China). The standard strain (Staphyloccocus aureus ATCC 29213) was provided by the RNAM Center for Marine Microbiology, South China Sea Institute of Oceanology (Guangzhou, China).
Plant Materials
The brown seaweed S. naozhouense was collected in July 2012 from Leizhou Peninsula of Guangdong Province, China. The specimens were identified by Professor Enyi Xie of the College 
Extraction and Isolation
The dried seaweeds (3 kg) were chopped and extracted with 75% EtOH at room temperature for 3 × 7 d. Removal of the solvent in vacuo afforded a syrupy residue (120 g), which was suspended in H 2 O followed by successive partition with petroleum ether, trichloromethane, ethyl acetate, and n-butanol. The trichloromethane extract (5.56 g) was subjected to column chromatography (CC) over silica gel (200-300 mesh) eluting with gradient CHCl 3 /acetone (100:0-0:100) to afford four fractions, Frs. 1-4. Fr.1 (100 mg) was subjected to CC eluting with gradient CHCl 3 /MeOH (25:1-10:1) to obtain two subfractions (Frs. 1-1-1-2) . Frs. 1-1 was purified by Sephadex LH-20 to yield 1 (1 mg). Frs. 1-2 was directly purified by recrystallization to yield 2 (6 mg). Frs. 2 (200 mg) was further subjected to silica gel column chromatography eluting with CHCl 3 /MeOH (25:1) to yield 3 (20 mg) and 4 (2 mg). Fr. 3 (200 mg) was subjected to CC eluting with CHCl 3 /MeOH (20:1) to yield 5 (1 mg), 6 (50 mg), and 7 (1 mg). Fr. 4 was purified by Sephadex LH-20 to yield 8 (1 mg). PTP1B (protein tyrosine phosphatase 1B) was expressed and purified in E. coli, and the enzymatic activities were measured at 30 • C by monitoring the hydrolysis of pNPP [15] . The enzymatic activities of PTP1B catalytic domain were also determined at 30 • C by monitoring the hydrolysis of pNPP. Dephosphorylation of pNPP generates p-nitrophenol, which can be monitored spectrophotometrically at 405 nm. In a 100-µL assay mixture containing 50 mM MOPS, pH 6.5, 2 mM pNPP, and recombinant enzymes, PTP1B activities were continuously monitored and the initial rate of the hydrolysis was determined from the early linear region of the enzymatic reaction kinetic curve as described by Zhang et al. [15] .
The inhibitory activity of compound 6 was tested against PTP1B by the colorimetric assay described by Zhang et al. Briefly, the compound was solubilized in DMSO at 20 µg/mL, and then added to a 96-well clear polystyrene plate (Corning, Action, MA, USA) with oleanolic acid (12.5 mM) as the positive inhibition. After adding an assay mixture (88 µL), 10 µL 300 nM GST-PTP1B was added to initiate the reaction. Then, the catalysis of pNPP was continuously monitored on SpectraMax 340 microplate reader (Molecular Devices, Sunnyvale, CA, USA) at 405 nm for 2 min at 30 • C in a final 100 µL volume containing 50 mM MOPS, pH 6.5, 2 mM pNPP, 30 nM PTP1B, and 2% DMSO. The IC 50 value was calculated from the non-linear curve fitting percent inhibition (% inhibition) to inhibitor 
DPPH Free Radical Scavenging Assay
The free radical scavenging potential of compound 6 was evaluated using the DPPH free radical scavenging assay described by Sharma and Bhat [16] . A total of 200 µL of the reaction mixture in a 96-well plate was composed of 100 µL of 0.1 mM DPPH (Sigma Aldrich, St. Louis, MO, USA) in methanol and 100 µL of different concentrations of test compound. The reaction mixture was then shaken well and incubated for 30 min in darkness at 37 • C. Meanwhile, a sample composed of 100 µL of methanol with 100 µL of 0.1 mM DPPH was taken as a control, while vitamin C (Shanxi Yishengtang Pharmaceutical Co., Ltd., Tongchuan, China) was taken as a reference material. The absorbance of reaction solution was measured at 517 nm with a plate reader (Thermo Multiskan MK3 spectrophotometer, Thermo Fisher Scientific, Waltham, MA, USA), and the percentage of scavenging capacity (%) was calculated by the following equation, where A Control stands for the absorbance of the control and A Treatment stands the absorbance of the treatment:
Scavenging capacity (%) = (1 − A Treatment /A Control ) × 100.
The DPPH IC 50 value is the concentration required to scavenge DPPH radical by 50%.
Antimicrobial Activity
Antimicrobial test for compound 6 was carried out against resistant microbes such as Candida albicans, MRSA, and Escherichia coli by disc diffusion method [17] . Briefly, a Petri dish was prepared with a base layer of Muller Hinton (MH) agar (10 mL), and then 0.1 mL culture with the
